PRDX2 and Müller cells in diabetic retinopathy
World Journal of Diabetes · 2026-11-15 · 17 (11)
DOI: 10.4239/wjd.124773 ↗Abstract
A possible new and different focus on diabetic retinopathy, particularly on neuroglial pathways, was proposed by Du et al in their article published in the World Journal of Diabetes . By measuring biomarker levels in vitro and in vivo , the authors highlighted the relationship between peroxiredoxin-2 (PRDX2) levels and diabetic retinopathy severity and reported that PRDX2 levels were independently associated with proliferative disease, thereby attributing to PRDX2 a role beyond that of angiogenic markers. High PRDX2 levels were found in human diabetic tissues and murine models, specifically in Müller glial cells and in glial cultures stimulated with a glucose-rich environment. The fundamental role of PRDX2 in Müller cell hyperreactivity, proliferation, and cytoskeletal remodeling was also confirmed by PRDX2 knockdown experiments. Gliotic transformation is stimulated by redox stress and is linked to activation of the RhoA/ROCK pathway through the loss of RhoGDI1-mediated inhibition. This study challenges conventional antioxidant paradigms and introduces new opportunities for neuroglia-centered treatment approaches in diabetic retinopathy.
EUVIMED